BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

BioPharma Pharma Research

Ascentage Pharma & AstraZeneca Collaborate on Phase III Study for CLL/SLL Treatment

The two companies will jointly conduct a registrational Phase III study of the Bcl-2 inhibitor, APG-2575 (lisaftoclax), in combination with AstraZeneca's B...

October 16, 2023 | News

HanAll, Daewoong, and NurrOn Launch Phase 1 Study for HL192

HanAll Biopharma and Daewoong Pharmaceutical marked a pivotal step forward in the development of HL192 (ATH-399A) for the potential treatment of Parkinso...

October 13, 2023 | News

GE HealthCare Expands Human Subject Research with Stanford Medicine Using Photon Counting CTi Technology

Unique from current CT technology, GE HealthCare’s proprietary photon counting CT design is engineered to leverage Deep Silicon detectors with the ...

October 10, 2023 | News

Kexing Biopharm Hosts High-end Forum for China-MENA & South Asia Pharma Cooperation in Emerging Markets

MENA and South Asia are recognized as pivotal regions for Kexing Biopharm's overseas business expansion. The event brought together industry experts and he...

October 10, 2023 | News

Everest Medicines' Partner Calliditas Shares NefIgArd Phase 3 Trial Data at ISIN Tokyo 2023

"The positive findings from biomarker and patient subgroup analyses from the Phase 3 NefIgArd study highlights that Nefecon® treatment results in ...

October 05, 2023 | News

ZEISS and Boehringer Ingelheim Collaborate on Early Eye Disease Detection to Prevent Vision Loss.

The partnership brings together their leading expertise in ophthalmological technology, data analytics, algorithms and the development of first-in-class tr...

October 03, 2023 | News

OBiO Launches GMP Facility Intelli-M for Rapid Delivery of Innovative Therapies

The launch of the new base in Shanghai will enhance OBiO's production and service capabilities in both China and the United States...

September 28, 2023 | News

Centre for Ion Beam Applications at NUS designated as IAEA's first Collaborating Centre in Singapore

The Centre for Ion Beam Applications (CIBA), a multidisciplinary research centre at the National University of Singapore (NUS), h...

September 21, 2023 | News

China's NMPA Recommends Priority Review for Cefepime-Taniborbactam in UTI Treatment

"Currently, the clinical challenges from multi-drug resistant infections are severe. The recommendation of priority review by CDE for cefepime-taniborbacta...

September 20, 2023 | News

Australia Launches National Study on Back and Neck Pain Risk Factors

The University of Adelaide's Experts Lead Landmark Australian Study on Back and Neck Pain A team of experts from the University of Adelaide is spearheadin...

September 18, 2023 | News

MGI Collaborates with National Cancer Centre Singapore for Asian Cancer Genomic Profiling

"We are excited to work with NCCS to uncover the unique molecular genomic composition of cancers prevalent in Asia by providing our DNBSEQ-G400 s...

September 18, 2023 | News

Samsung Biologics Expands Agreement with Bristol Myers Squibb to Manufacture Cancer Drug

Bristol Myers Squibb and Samsung Biologics have an existing manufacturing agreement for a commercial antibody cancer drug and have expanded the s...

September 18, 2023 | News

BioRay's Zuberitamab (Anruixi®) First Domestic Anti-CD20 Antibody Approved in China

In preclinical studies, Anruixi® showed stronger antibody-dependent cell-mediated cytotoxicity (ADCC), a larger volume of distribution at steady state,...

September 14, 2023 | News

Takara Bio Europe Launches Enzymes for mRNA Vaccine R&D

Takara Bio Europe (TBE) announced the launch of new High Quality (HQ) grade mRNA production enzymes "T7 RNA polymerase, HQ" and "Pyrophosphatas...

September 13, 2023 | News

Stay Connected